arrow
Back
N

Natasha B. Leighl

University Health Network

87H-index
963Paper Count
4.4WCitation Count
Published Papers 214
Publication Date
Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial
err2026-08-24
err0
PREAI
errXiuning Le; Antonio Passaro; Yuanyuan Zhao; Yan Huang; Janessa Laskin; Delvys Rodriguez-Abreu; Antonio Calles; Lyudmila Bazhenova; Giuseppe Lo Russo; Natasha B Leighl; Federico Cappuzzo; Nicolas Girard; Sanjay Popat; Wenfeng Fang; Yongzhong Luo; Wenting Li; Zhiyong He; Hui Zhao; Mingjun Li; Qibin Song
errShare
errSave
Binimetinib and encorafenib for the treatment of advanced solid tumors with non-V600E BRAF mutations: results from the Phase II BEAVER trial
err2026-01-03
err0
errOAAI
errApril A. N. Rose; Jennifer Maxwell; Emmanuelle Rousselle; Chantel L. Mukonoweshuro; Islam E. Elkholi; Melody Riaud; Marco Biondini; Erica Cianfarano; Isabel Soria-Bretones; Chantal Tobin; Meghan McGuire; Rhoda W. Y. Law; Andrew J. Elia; Ben X. Wang; Ian King; Tong Zhang; Trevor J. Pugh; Zaid Saeed Kamil; Marcus Butler; Frances A. Shepherd; Natasha B. Leighl; Albiruni Abdul Razak; Aaron Hansen; Samuel D. Saibil; Philippe L. Bedard; Peter M. Siegel; Lillian L. Siu; David W. Cescon; Anna Spreafico
errShare
errSave
Effects of serotonergic drugs on immune checkpoint inhibitor response: a pooled analysis of individual patient data from four Canadian Cancer Trials Group (CCTG) trials
err2025-11-01
err0
PREAI
errCourtney H Coschi; Keyue Ding; Dongsheng Tu; Christopher O’Callaghan; Natasha B Leighl; Francisco Vera-Badillo; Rosalyn A Juergens; Desiree Hao; Lesley Seymour; Daniel J Renouf; Eric Chen; Andrea S Fung; Pierre-Olivier Gaudreau
errShare
errSave
Liquid Biopsy in Lung Cancer: Tracking Resistance to Targeted Therapies
err2025-10-29
err0
errOAAI
errScarlet B. Urtecho; Beatriz Jimenez Munarriz; Mary R. Rabey; Natasha B. Leighl
errShare
errSave
Systemic therapy for brain metastases: a changing landscape
err2025-10-27
err0
PREAI
errKatarzyna J Jerzak; Natasha B Leighl; Arjun Sahgal
errShare
errSave
Bridging the Gap in Lung Cancer: a comprehensive global strategy for change
err2025-10-25
err0
PREAI
errKostas N. Syrigos; Mary E. Bussell; Humaid O. Al-Shamsi; Ola M. Khorshid; Roy S. Herbst; Sofia Angelaki; Natasha Leighl; Fred Hirsch; Heather Wakelee
errShare
errSave
A retrospective analysis exploring the association of pretreatment neutrophil-to-lymphocyte ratio and immune checkpoint inhibitor outcomes in patients with advanced NSCLC and liver metastases
err2025-10-22
err0
errOAAI
errMaisam Makarem; Tuan Hoang; Mitchell J. Elliott; Andrew Rabinovitch; Katrina Hueniken; Shelley Kuang; Sabine Schmid; Ming Sound Tsao; Tracy McGaha; Pamela S. Ohashi; Frances A. Shepherd; Penelope A. Bradbury; Geoffrey Liu; Natasha B. Leighl; Adrian Sacher; Sally C. M. Lau
errShare
errSave
Unresectable stage III non-small-cell lung cancer: state of the art and challenges
err2025-10-09
err0
PREAI
errJordi Remon; Antonin Levy; Romane Gille; Isabelle Martel-Lafay; Martina Bortolot; Lizza E. L. Hendriks; Corinne Faivre-Finn; Natasha Leighl; Martin Reck; Maurice Pérol
errShare
errSave
errShare
errSave
Early and locally advanced non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up†
err2025-08-28
err0
PREAI
errA. Zer; M.-J. Ahn; F. Barlesi; L. Bubendorf; D. De Ruysscher; P. Garrido; O. Gautschi; L.E. Hendriks; P.A. Jänne; K.M. Kerr; C. Mascaux; T. Mitsudomi; S. Peters; C. Rolfo; A. Sacher; S. Senan; P. Ugalde; N.B. Leighl
errShare
errSave
Cost-effectiveness analysis of pembrolizumab as an adjuvant treatment of early-stage non-small cell lung cancer following complete resection and platinum-based chemotherapy in Canada
err2025-07-21
err0
errOAAI
errSylvi Nguyen; Elizabeth Wehler; Chloe Langevin; Arielle Bensimon; Natasha B. Leighl; Sreetama Sarkar; Xiaohan Hu; Ruifeng Xu; Brian Matthew Lang; Diksha Vohra; Ashwini Arunachalam; Ralph P. Insinga
errShare
errSave
Molecular Tumor Boards: A consensus statement from the International Association for the Study of Lung Cancer
err2025-07-07
err0
PREAI
errMihaela Aldea; Julia K. Rotow; Maria Arcila; Matthew Hatton; Lynette Sholl; Christian Rolfo; Marco Tagliamento; Teodora Radonic; Kurt A. Schalper; Vivek Subbiah; Umberto Malapelle; Anja C. Roden; Rami Manochakian; Ming-Sound Tsao; Helena Linardou; Rina Hui; Silvia Novello; Alastair Greystoke; Anjali Saqi; Sylvie Lantuejoul; David M. Hwang; Kelly Nevins; Murry Wynes; Saiama Waqar; Yuchen Han; Yasushi Yatabe; Wei-Chin Chang; Takuo Hayashi; Tae-Jung Kim; Paul Hofman; Fabio Tavora; Fred R. Hirsch; Valeria Denninghoff; Natasha B. Leighl; Alexander Drilon; Wendy A. Cooper; Sanja Dacic; Pranshu Mohindra; Nick Pavlakis; Fernando Lopez-Rios
errShare
errSave
Mitigation and management of adverse events associated with amivantamab therapy
err2025-07-01
err0
errOAAI
errFlorez, Narjust; LeBoeuf, Nicole R.; Rotow, Julia; Marks, Jennifer A.; Sabari, Joshua K.; Arrieta, Oscar; Baldotto, Clarissa; Gosain, Rahul; Zawisza, Dianne; McDonald, Stephanie; Dylgjeri, Emanuela; Cifuentes, Paul; McLellan, Beth; Leighl, Natasha B.
errShare
errSave
Management of Patients with Early-Stage Non-Small Cell Lung Cancer: An American College of Chest Physicians Clinical Practice Guideline
errCHEST
IF8.6
err2025-06-23
err0
PREAI
errJohn Howington; Lesley H. Souter; Douglas Arenberg; Justin Blasberg; Frank Detterbeck; Farhood Farjah; Michael Lanuti; Natasha Leighl; Gregory M. Videtic; Sudish Murthy
errShare
errSave
LEAP-008: Lenvatinib Plus Pembrolizumab for Metastatic NSCLC That Has Progressed After an Anti–PD-(L)1 Plus Platinum Chemotherapy
err2025-06-03
err0
PREAI
errNatasha B. Leighl; Luis Paz-Ares; Delvys Rodriguez Abreu; Rina Hui; Sofia Baka; Frédéric Bigot; Makoto Nishio; Alexey Smolin; Samreen Ahmed; Adam J. Schoenfeld; Sameh Daher; Diego L. Cortinovis; Vincenzo Di Noia; Helena Linardou; Justin F. Gainor; Corina Dutcus; Chinyere E. Okpara; Xuan Deng; Debra Kush; Ashwini Arunachalam; Andrew Song; Byoung Chul Cho
errShare
errSave
Amivantamab in Participants With Advanced NSCLC and MET Exon 14 Skipping Mutations: Final Results From the CHRYSALIS Study
err2025-05-16
err0
PREAI
errMatthew G. Krebs; Byoung Chul Cho; Sandrine Hiret; Ji-Youn Han; Ki Hyeong Lee; Casilda Llácer Pérez; Filippo De Braud; Eric B. Haura; Rachel E. Sanborn; James Chih-Hsin Yang; Catherine A. Shu; Koichi Goto; Makoto Nishio; Jun Zhao; Zhijie Wang; Pascale Tomasini; Enriqueta Felip; Jonathan W. Goldman; Sai-Hong Ignatius Ou; Michael Boyer; Grace Gao; Siyang Qu; Joshua C. Curtin; Xuesong Lyu; Robert W. Schnepp; Priya Kim; Meena Thayu; Roland E. Knoblauch; Patricia Lorenzini; Mahadi Baig; Alexander I. Spira; Natasha B. Leighl
errShare
errSave
Intracranial and systemic progression on amivantamab in platinum-treated epidermal growth factor receptor exon 20 insertion-mutated advanced non-small cell lung cancer
err2025-05-10
err0
PREAI
errNatasha B. Leighl; Jose Trigo; Keunchil Park; Se-Hoon Lee; Nicolas Girard; Santiago Viteri; Pilar Garrido; Matthew G. Krebs; Meena Thayu; Roland E. Knoblauch; John Xie; Joshua M. Bauml; Robert W. Schnepp; Anil Londhe; Yichuan Xia; Parthiv J. Mahadevia; Byoung Chul Cho
errShare
errSave
Real-World Creatinine-Based Estimates of Acute and Chronic Kidney Dysfunction in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung Cancer Receiving Tyrosine Kinase Inhibitors
err2025-04-08
err0
PREAI
errLouis Pinard; Avinash Rao Ullur; Louis Everest; Luna Jia Zhan; Rajeevan Selvaratnam; Karmugi Balaratnam; Khaleeq Khan; Sabine Schmid; Simren Chotai; Devalben Patel; Faisal Al-Agha; Benjamin Grant; M. Catherine Brown; Roula Raptis; Wei Xu; Patrick Moriarty; Frances A. Shepherd; Adrian G. Sacher; Natasha B. Leighl; Penelope A. Bradbury; Geoffrey Liu; Abhijat Kitchlu
errShare
errSave
Prognostic and predictive effects of TP53 co-mutation in patients with non-small cell lung cancer with rare treatable driver mutations
err2025-02-01
err0
PREAI
errFeng, Jamie; Hueniken, Katrina; Fan, Zhen Jason; Zhan, Luna Jia; Faour, Elizabeth; Corke, Lucy; Alghabban, Abdulrahman; Leighl, Natasha B.; Liu, Geoffrey; Bradbury, Penelope A.; Sacher, Adrian; Eng, Lawson; Stockley, Tracy L.; Tsao, Ming Sound; Shepherd, Frances A.
errShare
errSave
The continually evolving landscape of novel therapies in oncogene-driven advanced non-small-cell lung cancer
err2025-01-07
err0
errOAAI
errMelosky, Barbara; Juergens, Rosalyn A.; Banerji, Shantanu; Sacher, Adrian; Wheatley-Price, Paul; Snow, Stephanie; Tsao, Ming-Sound; Leighl, Natasha B.; Martins, Ilidio; Cheema, Parneet; Liu, Geoffrey; Chu, Quincy S. C.
errShare
errSave